State of the Science Summit on Prostate Cancer | Conference

Prostate Cancer Screening and Surveillance Continue to Evolve

March 30th 2018

William K. Kelly, DO, discusses the evolving imaging techniques and emerging therapeutic approaches in prostate cancer.

Expert Discusses Bone-Targeting Agents in Prostate Cancer

March 29th 2018

Robert B. Den, MD, discusses bone-targeting agents in prostate cancer and the potential future of combinations.

Dr. Trabulsi on Clinical Trial Combination Approaches in Prostate Cancer

March 28th 2018

Edouard J. Trabulsi, MD, FACS, professor, co-director, Multidisciplinary Genitourinary Oncology Center, Prostate Diagnostic Center, vice chair of research, director, Division of Urologic Oncology, Department of Urology, Sidney Kimmel Cancer Center, discusses clinical trials that are investigating combination approaches for patients with prostate cancer.

Genetic Testing Helps Guide Treatment in Prostate Cancer

March 28th 2018

Veda Giri, MD, discusses the developing role of genetic testing for the screening and management of patients with prostate cancer.

Gomella Gives Predictions for Prostate Cancer Advances in 2018

March 25th 2018

Leonard G. Gomella, MD, shares his insight on this year's expected advances in the field of prostate cancer.

Dr. Mann on Differences Between Treatments for Prostate Cancer

March 23rd 2018

Mark J. Mann, MD, assistant professor, Sidney Kimmel Cancer Center, Thomas Jefferson Hospital, discusses the differences between treatment options for patients with prostate cancer subtypes.

Frontline Advances Continue in Castration-Sensitive Prostate Cancer

March 23rd 2018

James Luke Godwin, MD, recaps recent advancements in frontline metastatic castration-sensitive prostate cancer and highlights emerging agents with potential in this space.

Dr. Giri Discusses Testing for Inherited Prostate Cancer

March 23rd 2018

Veda Giri, MD, associate professor, Thomas Jefferson University Hospital, discusses testing for inherited prostate cancer.

Dr. Gomella on Screening in Prostate Cancer

March 22nd 2018

Leonard Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel Cancer Center Network, Thomas Jefferson University Hospital, encourages early screening for prostate cancer.

Dr. Den Discusses Bone-Targeting Agents in Prostate Cancer

March 20th 2018

Robert B. Den, MD, associate professor of radiation oncology, Thomas Jefferson University Hospital, discusses bone-targeting agents in prostate cancer.